InvestorsHub Logo
Followers 50
Posts 3909
Boards Moderated 0
Alias Born 03/12/2011

Re: Lykiri post# 455837

Friday, 04/01/2022 4:48:25 AM

Friday, April 01, 2022 4:48:25 AM

Post# of 704237

Quote:
She went more in-depth into the details of the SAP with external control arms.


Dr Bala,

I agree, interesting presentations today at the University of Miami by Dr. Liau.

Slide : Statistical analysis plan (SAP) for RCT with cross-over arm.
Linda Liau:
Quote:
"Before the trial was unblinded this was the statistical analysis plan that was submitted to the FDA."




Thank you Lykiri.

This clearly shows, in my view, that the new endpoints and the comparison with external Placebos have been accepted by the FDA!
Not very nice for the cabal overhere.

Thanks again and best to you.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News